<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BBIO
BridgeBio
$
()


  • BridgeBio to reduce gene therapy budget more than $50M

    9/11/2024 - 10:45am
  • BridgeBio gene-therapy results mixed, but 'still a win,' says BofA

    9/11/2024 - 07:36am
  • Competitor disappointments bode well for Neurocrine, says BofA

    9/11/2024 - 07:20am
  • BridgeBio reports results from Phase 1/2 open-label trial of BBP-631

    9/10/2024 - 16:49pm
  • BridgeBio announces FDA grants RMAT designation to BBP-812

    9/10/2024 - 16:46pm
  • BridgeBio reports inducement grants under Nasdaq listing rule

    9/6/2024 - 07:33am
  • Biotech Alert: Searches spiking for these stocks today

    9/5/2024 - 11:02am
  • Piper starts BridgeBio with Overweight into expected acoramidis approval

    9/4/2024 - 06:39am
  • BridgeBio initiated with bullish view at Piper Sandler

    9/4/2024 - 05:21am
  • BridgeBio participates in a conference call with JPMorgan

    9/3/2024 - 11:19am
  • BridgeBio presented additional data from an analysis of acoramidis studies

    8/30/2024 - 10:53am
  • JPMorgan healthcare analysts hold an analyst/industry conference call

    8/30/2024 - 10:38am
  • BridgeBio announces initiation of scientific collaboration with CarDS Lab

    8/26/2024 - 07:34am
  • BridgeBio launches MyAchonJourney online resource

    8/19/2024 - 07:32am
  • BridgeBio reports inducement grants under Nasdaq listing rule

    8/8/2024 - 08:29am
dynamic_feed Breaking News